- Report
- February 2024
- 180 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Report
- November 2023
- 180 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Report
- November 2023
- 180 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Report
- October 2023
- 185 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Report
- October 2023
- 190 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Report
- October 2023
- 178 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Report
- March 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- March 2024
- 200 Pages
Global
From €3956EUR$4,150USD£3,372GBP
- Report
- December 2023
- 115 Pages
Global
From €4290EUR$4,500USD£3,657GBP
- Report
- January 2024
- 146 Pages
Global
From €4052EUR$4,250USD£3,454GBP
- Report
- January 2024
- 140 Pages
Global
From €4052EUR$4,250USD£3,454GBP
- Report
- December 2023
- 145 Pages
Global
From €4242EUR$4,450USD£3,616GBP
- Report
- November 2023
- 140 Pages
Global
From €4242EUR$4,450USD£3,616GBP
- Report
- May 2024
- 200 Pages
Global
From €3956EUR$4,150USD£3,372GBP
- Report
- May 2024
- 200 Pages
Global
From €3956EUR$4,150USD£3,372GBP
- Report
- March 2024
- 200 Pages
Global
From €3956EUR$4,150USD£3,372GBP
- Report
- January 2024
- 200 Pages
Global
From €3956EUR$4,150USD£3,372GBP
- Report
- October 2023
- 145 Pages
Global
From €3003EUR$3,150USD£2,560GBP
- Report
- October 2023
- 145 Pages
Global
From €3003EUR$3,150USD£2,560GBP
- Report
- August 2023
- 145 Pages
Global
From €3003EUR$3,150USD£2,560GBP
Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more